FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048776219> ?p ?o ?g. }

• W3048776219 endingPage "e00222" @default.
• W3048776219 startingPage "e00222" @default.
• W3048776219 abstract "INTRODUCTION: AXA1665 is a novel investigational amino acid (AA) composition specifically designed to impact AA imbalance, ammoniagenesis, and dysregulated anabolic activity associated with cirrhosis. METHODS: This 2-part study examined AXA1665 effects on safety, tolerability, and hepatic/muscle physiology in subjects with Child–Pugh A and B cirrhosis. Part 1 established plasma ammonia and AA concentration baselines with a standardized protein supplement. Part 2 included two 15-day domiciled periods separated by a 14-day washout. In period 1, subjects were randomly distributed to 2 groups: AXA1665 14.7 g t.i.d. (group 1) or control t.i.d. (group 2). In period 2, subjects from group 1 crossed over to control and those in group 2 crossed over to AXA1665 4.9 g t.i.d. All subjects were maintained on standard of care (standardized meals; 30-minute daily, supervised, mandatory physical activity; and daily late-evening snack). RESULTS: In parts 1 and 2, 23 and 17 participants were enrolled, respectively. Dose-dependent increases were observed in plasma concentrations of AXA1665-constituent AAs. Fasted branched-chain AA-to-aromatic AA and valine-to-phenylalanine ratios were both increased (AXA1665 14.7 g t.i.d. control-adjusted change: 44.3% ± 2.7% and 47.2% ± 3.9%, respectively; P < 0.0001). Despite provision of additional nitrogen, mean fasted plasma ammonia concentration at day 15 numerically decreased (−21.1% in AXA1665 14.7 g t.i.d. vs −3.8% in control; P > 0.05). AXA1665 14.7 g t.i.d. produced a leaner body composition and significantly decreased Liver Frailty Index at day 15 vs control (−0.70 ± 0.15 vs −0.14 ± 0.17; P < 0.05). AXA1665 was safe and well tolerated. DISCUSSION: AXA1665 has potential to mitigate core metabolic derangements associated with cirrhosis." @default.
• W3048776219 created "2020-08-18" @default.
• W3048776219 creator A5003058857 @default.
• W3048776219 creator A5027534432 @default.
• W3048776219 creator A5036758613 @default.
• W3048776219 creator A5047733946 @default.
• W3048776219 creator A5058809875 @default.
• W3048776219 creator A5061396178 @default.
• W3048776219 creator A5068446917 @default.
• W3048776219 creator A5070639714 @default.
• W3048776219 creator A5074565758 @default.
• W3048776219 creator A5084369957 @default.
• W3048776219 creator A5087328928 @default.
• W3048776219 creator A5091864893 @default.
• W3048776219 date "2020-08-01" @default.
• W3048776219 modified "2023-10-07" @default.
• W3048776219 title "Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child–Pugh A and B Cirrhosis" @default.
• W3048776219 cites W1571954921 @default.
• W3048776219 cites W1619454850 @default.
• W3048776219 cites W1882094537 @default.
• W3048776219 cites W1989199273 @default.
• W3048776219 cites W1993700202 @default.
• W3048776219 cites W2000692218 @default.
• W3048776219 cites W2003012008 @default.
• W3048776219 cites W2007791111 @default.
• W3048776219 cites W2017222370 @default.
• W3048776219 cites W2031847842 @default.
• W3048776219 cites W2036787362 @default.
• W3048776219 cites W2044756609 @default.
• W3048776219 cites W2069236385 @default.
• W3048776219 cites W2072900069 @default.
• W3048776219 cites W2079936247 @default.
• W3048776219 cites W2082953106 @default.
• W3048776219 cites W2083215798 @default.
• W3048776219 cites W2120073134 @default.
• W3048776219 cites W2127764242 @default.
• W3048776219 cites W2132199186 @default.
• W3048776219 cites W2141802051 @default.
• W3048776219 cites W2155403338 @default.
• W3048776219 cites W2155576364 @default.
• W3048776219 cites W2166834388 @default.
• W3048776219 cites W2166966082 @default.
• W3048776219 cites W2171207360 @default.
• W3048776219 cites W2261020375 @default.
• W3048776219 cites W2316788154 @default.
• W3048776219 cites W2395923870 @default.
• W3048776219 cites W2460063783 @default.
• W3048776219 cites W2552685276 @default.
• W3048776219 cites W2588938745 @default.
• W3048776219 cites W2606209221 @default.
• W3048776219 cites W2606537121 @default.
• W3048776219 cites W2616663756 @default.
• W3048776219 cites W2627050072 @default.
• W3048776219 cites W2744982526 @default.
• W3048776219 cites W2746114113 @default.
• W3048776219 cites W2774247771 @default.
• W3048776219 cites W2788299528 @default.
• W3048776219 cites W2794383463 @default.
• W3048776219 cites W2800221985 @default.
• W3048776219 cites W2801599806 @default.
• W3048776219 cites W2804625278 @default.
• W3048776219 cites W2805536661 @default.
• W3048776219 cites W2807586373 @default.
• W3048776219 cites W2808431838 @default.
• W3048776219 cites W2810276844 @default.
• W3048776219 cites W2885261236 @default.
• W3048776219 cites W2885967217 @default.
• W3048776219 cites W2941435325 @default.
• W3048776219 cites W2955514214 @default.
• W3048776219 cites W3000031034 @default.
• W3048776219 cites W3002179283 @default.
• W3048776219 cites W3014209768 @default.
• W3048776219 cites W4211260107 @default.
• W3048776219 doi "https://doi.org/10.14309/ctg.0000000000000222" @default.
• W3048776219 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7423914" @default.
• W3048776219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32955200" @default.
• W3048776219 hasPublicationYear "2020" @default.
• W3048776219 type Work @default.
• W3048776219 sameAs 3048776219 @default.
• W3048776219 citedByCount "11" @default.
• W3048776219 countsByYear W30487762192020 @default.
• W3048776219 countsByYear W30487762192021 @default.
• W3048776219 countsByYear W30487762192022 @default.
• W3048776219 countsByYear W30487762192023 @default.
• W3048776219 crossrefType "journal-article" @default.
• W3048776219 hasAuthorship W3048776219A5003058857 @default.
• W3048776219 hasAuthorship W3048776219A5027534432 @default.
• W3048776219 hasAuthorship W3048776219A5036758613 @default.
• W3048776219 hasAuthorship W3048776219A5047733946 @default.
• W3048776219 hasAuthorship W3048776219A5058809875 @default.
• W3048776219 hasAuthorship W3048776219A5061396178 @default.
• W3048776219 hasAuthorship W3048776219A5068446917 @default.
• W3048776219 hasAuthorship W3048776219A5070639714 @default.
• W3048776219 hasAuthorship W3048776219A5074565758 @default.
• W3048776219 hasAuthorship W3048776219A5084369957 @default.
• W3048776219 hasAuthorship W3048776219A5087328928 @default.
• W3048776219 hasAuthorship W3048776219A5091864893 @default.
• W3048776219 hasBestOaLocation W30487762191 @default.

• next